{
  "documentMetadata": {
    "title": "Onychomycosis",
    "lastUpdated": "2024-03-27",
    "sourceFile": "Onychomycosis.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Fungal infection of the fingernail or toenail.",
        "Main patterns of onychomycosis include distolateral subungual, proximal subungual (associated with immunosuppressive condition, HIV), superficial and total dystrophic.",
        "Diagnosis confirmed by microscopic evaluation and culture of nail clippings."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Dermatophytes (Trichophyton rubrum and T. mentagrophytes) account for most of cases",
        "Rarely candida and molds can cause disease"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Fingernail, adult:"
        },
        {
          "type": "list",
          "items": [
            "Terbinafine 250 mg po q24h x 6 weeks (79% effective)",
            "Itraconazole (~ 60-70% effective)",
            "200 mg po q24h x 3 months OR",
            "200 mg po bid x 1 week/month x 2 months"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Fingernail, pediatric:"
        },
        {
          "type": "list",
          "items": [
            "10-20 kg: Terbinafine 62.5 mg po q24h x6 weeks",
            "20-40 kg: Terbinafine 125 mg po q24h x6 weeks",
            ">40 kg: adult Terbinafine dose"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Toenail, adult:"
        },
        {
          "type": "list",
          "items": [
            "Terbinafine 250 mg po q24h x 12 weeks (66-76% effective)",
            "Itraconazole (~ 60% effective)",
            "200 mg po q24h x 3 months OR",
            "200 mg bid x 1 wk/mo x 3–4 months"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Toenail, pediatric:"
        },
        {
          "type": "list",
          "items": [
            "10-20 kg: Terbinafine 62.5 mg po q24h x12 weeks",
            "20-40 kg: Terbinafine 125 mg po q24h x12 weeks",
            ">40 kg: adult Terbinafine dose"
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Fingernail:"
        },
        {
          "type": "list",
          "items": [
            "Fluconazole 150-300 mg po q wk x 3-6 months (~50% effective)"
          ]
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "paragraph",
          "text": "Toenail:"
        },
        {
          "type": "list",
          "items": [
            "Fluconazole 150–300 mg po q wk x 6–12 months (~50% effective)",
            "Efinaconazole (Jublia) 10% solution applied once daily for 48 weeks for the topical treatment of toenail onychomycosis due to T. rubrum and T. mentagrophytes. Complete or almost complete cure, 23-26% (package insert).",
            "Tavaborole (Kerydin) 5% solution applied once daily for 48 weeks. Complete or almost complete cure rates of 15-18%. Ref.: Med Lett Drugs Ther 57:35, 2015."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Terbinafine was associated with a higher cure rate for toenail fungal infections than azoles in a meta-analysis (JAMA 319: 397, 2018). Terbinafine: serious but rare cases of hepatic failure have been reported; avoid in those with chronic or active liver disease.",
        "The role of nail removal in treatment is unclear and may add benefit in cases due to drug-resistant fungi.",
        "FDA has approved laser therapy that is temporarily effective. Reported expense of each treatment: $300 - $1000 (Med Lett Drugs Ther 55:15, 2013)."
      ]
    }
  ]
}